Filing Details

Accession Number:
0001055726-17-000020
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-04-03 17:08:59
Reporting Period:
2017-03-30
Filing Date:
2017-04-03
Accepted Time:
2017-04-03 17:08:59
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1055726 Inovio Pharmaceuticals Inc. INO Surgical & Medical Instruments & Apparatus (3841) 330024450
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1464549 Joseph Jong Kim 660 W. Germantown Pike Suite 110
Plymouth Meeting PA 19462
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-03-30 73,590 $5.08 2,164,887 No 4 M Direct
Common Stock Disposition 2017-03-30 73,590 $6.51 2,091,297 No 4 S Direct
Common Stock Acquisiton 2017-03-31 73,590 $5.08 2,164,887 No 4 M Direct
Common Stock Disposition 2017-03-31 73,590 $6.57 2,091,297 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock Option Disposition 2017-03-30 73,590 $0.00 73,590 $5.08
Common Stock Common Stock Option Disposition 2017-03-31 73,590 $0.00 73,590 $5.08
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
73,590 2007-01-18 2017-01-18 No 4 M Direct
0 2007-01-18 2027-01-18 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,750,000 Indirect By Family Limited Partnership
Common Stock 33,563 Indirect By Daughter: EK
Common Stock 33,775 Indirect By Son: JK1
Common Stock 5,975 Indirect By Spouse
Common Stock 33,533 Indirect By Son: JK2
Footnotes
  1. The term of these stock option was extended by 14 days after the expiration of the Company's blackout period.